---
type: connection
sweep_date: 2026-05-16
sweep_sha: 91acf49
section_index: 5
global_index: 5
pass3_verdict: Confirmed, prioritize
overlap_tag: EXTENSION
---

# The gout genetic variants unified index (`gout-genetic-variants.md`) surfaces a coverage gap for East Asian populations that the corpus's primarily European-ancestry framing underweights — and the multilingual research default rule in CLAUDE.md provides the tooling to close it.

5. **The gout genetic variants unified index (`gout-genetic-variants.md`) surfaces a coverage gap for East Asian populations that the corpus's primarily European-ancestry framing underweights — and the multilingual research default rule in CLAUDE.md provides the tooling to close it.** *Supported.* `[CHAIN-DEPTH: 1]` `[PHASE-A-MATCH: partial]`
   - *Documents Connected:* `gout-genetic-variants.md`, `abcg2-modulators.md`, `uricase-abcg2-genotype-stratification-computational.md`, `CLAUDE.md`
   - *Page-pair linkage:* `gout-genetic-variants.md` is a new page (2026-05-16) that cross-references `abcg2-modulators.md` and `uricase-abcg2-genotype-stratification-computational.md`. Its Category 1 table explicitly notes the Q141K ancestry-frequency gradient (T allele ~10–15% European vs. ~30% East Asian) and the URAT1 W258X enrichment in Japanese/Korean populations. The page's "Open questions / coverage gaps" section #7 explicitly names the East-Asian-literature gap: "there is likely substantial Chinese-language (CNKI, WanFang) and Japanese-language (J-STAGE, CiNii) gout-cohort data — particularly for Q141K, HLA-B*58:01, and URAT1 W258X — that has not been ingested into this index."
   - *Why It Matters:* The platform's genotype-stratified intervention modeling (comp-019, Q141K rescue thesis, butyrate dual-mechanism lever) is primarily anchored on European-ancestry cohort data. But the populations with the highest Q141K allele frequency (East Asian, ~30%) and the highest HLA-B*58:01 frequency (Han Chinese ~6–8%, Korean ~10–12%) are precisely the populations where the platform's personalized-medicine thesis has the largest addressable demographic. The corpus is missing the primary literature from the populations where the interventions would have the most impact. The CLAUDE.md global-multilingual rule provides the tooling to close this gap at zero marginal cost — a CNKI/WanFang/J-STAGE subagent pass would ingest the East Asian gout-cohort literature and update the variant frequency + intervention-response tables.
   - *Suggested Action:* Queue a multilingual lit scan subagent task: "For ABCG2 Q141K (rs2231142), URAT1 W258X (rs121907892), and HLA-B*58:01, retrieve allele frequencies and gout-association effect sizes from CNKI, WanFang, J-STAGE, and CiNii. Update `gout-genetic-variants.md` Category 1 and Category 6 tables with East Asian population-specific data. Flag any intervention-response data (e.g., Q141K-stratified allopurinol response in Japanese cohorts) not currently in the corpus." Cost: $0, ~1–2 hours subagent time. This is the single highest-leverage multilingual task in the current corpus.

> **Pass 3 review — Confirmed, prioritize.** `[OVERLAP: EXTENSION]` The population-coverage gap is material: `gout-genetic-variants.md` carries the Q141K ancestry-frequency gradient and HLA-B*58:01 pharmacogenetic relevance, while `CLAUDE.md` explicitly requires CNKI/WanFang/J-STAGE/CiNii-style multilingual source ingestion by default. A targeted East Asian gout-cohort scan is directly actionable and should change genotype-frequency tables, trial-power assumptions, and HLA-B*58:01/allopurinol-routing guidance if it finds cohort-specific effect sizes.
